For the post hoc analyses, the EEG activity (with all doses combined) after a single intravenous administration of NX210 over time showed a trend for increasing variation in the alpha power bands ( p = 0.84), with a maximum observed at 40 min (17.5% [SE = 16.9]); this variation was sustained at 24 h and 48 h (14.3% [SE = 19.5] and 13.2% [SE = 13.1], respectively) (Fig. 5 ).
Inhibition of CoQ synthesis through 4‐NB treatment caused a significant increase in TST and SUOX mRNA transcript levels (200 and 168% of controls; P = 0.02 and P = 0.04), and showed a trend toward an increase in SQR and ETHE1 mRNA transcript levels (127 and 158% of controls; P = 0.84 and P = 0.15; Fig EV3 A).
larvae showed a trend toward higher cumulative mortality (75%), no significant differences in survival were detected among groups (log-rank test, p = 0.8457).
Group A showed a trend of longer survival than group D (12 vs. 7 months, p=0.85).
ECV performed significantly better compared to T2-SI in comparison to remote myocardium (p = 0.037) and showed a trend to be superior to T2-imaging in comparison with skeletal muscle (p=0.85).
Patients with progression within the CNS showed a trend to poorer OS compared to those without (median OS 6.0 months (95% CI: 2.1–9.9) versus 9.0 (95% CI: 7.5–10.5), P = 0.862).
However, Post_EVs showed a trend in the increase of circulating CD31 + and CD106+ (p = 0.87) EVs, suggesting the activation of the vascular system and the release of EVs from endothelial cells, as well as increase in IB4+ and Irisin+ (p = 0.37 and p = 0.25 respectively) EVs, respectively released by microglia cells and muscles.
Although peri‐TLS positive patients showed a trend toward improved survival compared to TLS-negative individuals, the differences were not statistically significant (DFI, P = 0.88; PFI, P = 0.54).
When the participant was running barefoot, the percentage of FFS showed a trend towards increasing with increasing running speeds, albeit with insignificance in the linear analysis (χ 2 = 2.26, p = 0.89).
Similarly, the major allele of CYP2A6*2 showed a trend of association with increased likelihood of being a former smoker (OR = 1.03, 95% CI 0.72–1.47, p = 0.89), although the results were not statistically significant.
The imbalance of out degree index analysis showed a trend similar to the that present in CTRL subjects (p = 0.89, F = 0.46) ( Fig. 3c ), characterised by distorted condition values lower than mute and normal conditions; similarly the imbalance of local efficiency index analysis did not reveal any significant difference (p = 0.478, F = 0.857) ( Fig. 4c ).
Maximal load to failure showed a trend to be lower in humeri of rats fed a low protein diet ( P = 0.91).
CIK immunotherapy, cytotoxic lymphocyte (HR = 0.69, 95% CI 0.44–1.10), and cilengitide (HR = 0.79, 95% CI 0.58–1.06) showed a trend toward significant alkylating agents ( P = .91) followed by TTF ( P = .84) and CIK immunotherapy ( P = .78) ranked the first 3 treatments that improved OS ( Figure 4A ).
Neither the station (Wald χ 2 =0.013,p=0.90) nor the iteration of the study (Wald χ 2 =3.18,p=0.075) influenced ratings of the fluency of presentations, although as the latter showed a trend towards significance we included its interaction with the “describing” condition in the model which was non-significant (Wald χ 2 =0.01,p=0.91) and changed the findings only minimally.
Moreover, although the use of awake-PP with HFNO showed a trend toward delaying intubation compared to HFNO alone, early use of awake-PP did not affect 28-day mortality (RR, 1.04; 95% confidence interval [CI], 0.40–2.72; P = 0.92).
Growth-Associated Protein 43 Growth-associated protein 43 IENF in calf skin showed a trend for an increase in NFCI ( p = 0.92; Figure 6 ).
The biological activity of AMPA and GABA receptors showed a trend toward reduction by 30% after 87 hrs (Fig. 3b–c , AMPA F (6,33) = 0.2973, p = 0.93; GABA F (6,41) = 0.6263, p = 0.71) but the E/I ratio was preserved (Fig. 3d ).
In the measurable cohort, the CNS objective response rates showed a trend towards more complete responses, suggesting that the addition of chemotherapy may improve the depth of response over monotherapy (48% vs. 16%, P=0.93).
Among nulliparous participants, the observed differences showed a trend in favour of progesterone (30.0% versus 15.9%, RR 1.88; 95% CI [1.03,3.43], interaction p = 0.93).
In the FcRn KO mice, chronic dosing of TfRMAb-EPO showed a trend toward a decrease in tissue levels in the kidney, spleen, and brain by 83.5% ( p = 0.93), 95.2% ( p = 0.92), and 99.7% ( p = 0.43), respectively, compared with FcRn KO mice that received a single dose of TfRMAb-EPO ( Figure 2 A,C,D).
Even though the statistical analysis of the RECIST CT-scan results showed a trend that suggests predictive power, it was not significant ( p = 0.931).
Although not significant, mutations in LUC7L2 and SAP130 showed a trend towards co-occurrence (odds ratio = 2.883, p = 0.9434, Fisher's exact test).
While the Kaplan–Meier curves showed a trend towards reduced survival in Hepatitis C/HIV co-infected patients, the Log Rank test did not reveal statistically significant differences ( p = 0.953), especially not in a critical short-term ICU-setting.
3 I, F = 7.012, FDR p = 0.15) and that of hippocampal FKBP52 showed a trend for statistical significance ( Fig. 3 I, F = 3.504, FDR p = 0.96).
The tests showed a trend in the opposite direction, t (88) = -1.78, p = 0.960, d = -0.37, BF = 0.874.